Home/RS Oncology/Dean Fennell, MRCP, FRCP
DF

Dean Fennell, MRCP, FRCP

Clinical Advisory Board Director

RS Oncology

Therapeutic Areas

RS Oncology Pipeline

DrugIndicationPhase
RSO-021Malignant Pleural Mesothelioma, Metastatic Breast Cancer, Metastatic Ovarian Cancer, Non-Small Cell Lung CancerPhase 2